Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity

This publication has 34 references indexed in Scilit:

• Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperature
  Published by Elsevier ,2003
• Statistics Notes: Analysing controlled trials with baseline and follow up measurements
  BMJ, 2001
• Ovulatory and Metabolic Effects of d-Chiro-Inositol in the Polycystic Ovary Syndrome
  New England Journal of Medicine, 1999
• Effects of Metformin on Spontaneous and Clomiphene-Induced Ovulation in the Polycystic Ovary Syndrome
  New England Journal of Medicine, 1998
• Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome
  Fertility and Sterility, 1998
• Menstrual Cyclicity After Metformin Therapy in Polycystic Ovary Syndrome
  Obstetrics & Gynecology, 1997
• Role of Hyperinsulinemia in the Pathogenesis of the Polycystic Ovary Syndrome, and Its Clinical Implications
  Seminars in Reproductive Medicine, 1997
• Decreases in Ovarian Cytochrome P450c17α Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary Syndrome
  New England Journal of Medicine, 1996
• Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone
  New England Journal of Medicine, 1994
• Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy
  Metabolism, 1994